Tenth Annual Controversies in Hematologic Malignancies Virtual Symposium

April 17, 2021

This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include management of myelodysplastic syndromes, management of myeloproliferative neoplasms, germline/hereditary myeloid malignancy syndromes, immunotherapy update in myeloma, AL amyloidosis, managing transplant ineligible myeloma patients, relapsed refractory DLBCL, NHL cellular therapies and updates in mantle cell lymphoma treatment. 

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses and Allied Health Professionals

Learning Objectives

The aim of this conference is to highlight major controversies in the treatment of hematological malignancies. At the completion of this activity, attendees will be able to make therapeutic decisions based on the available data, realizing the ongoing debate in those areas.

Additional information

Contact

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 3.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.75 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
  • 3.75 NP Contact Hours
Course opens: 
02/22/2021
Course expires: 
06/30/2021
Event starts: 
04/17/2021 - 8:00am
Event ends: 
04/17/2021 - 12:05pm
Cost:
$0.00

8:00-8:05am | Introduction

Myeloid Malignancy Block

8:05-8:25am | Updates in the Management of Myelodysplastic Syndromes - Guru Subramanian Guru Murthy, MD, MS

8:25-8:45am | Updates in the Management of Myeloproliferative Neoplasms - Laura Michaelis, MD                    

8:45-9:05am | Hereditary Myeloid Malignancy Disorders: For Whom, Why & How in 2021 - Jane Churpek, MD       

9:05-9:20am | Myeloid Malignancy Panel Discussion - All Speakers                     

9:20-9:35am | Break

Plasma Cell Disorder Block

9:35-9:55am | Immunotherapy Updates in Myeloma - Saurabh Chhabra, MD, MS

9:55-10:15am | Recent Advances in the Treatment of AL Amyloidosis Updates - Suzanne Lentzsch, MD, PhD                    

10:15-10:35am | How to Manage Transplant Ineligible Myeloma Patients - Meera Mohan, MD       

10:35-10:50am | Plasma Cell Disorder Panel Discussion - All Speakers                     

10:50-11:05am | Break

Lymphoma Block

11:05-11:25am | Updates in New Therapies in Relapsed Refractory DLBCL - Suma Devata, MD

11:25-11:45am | Selecting Optimal Cell-Based Therapy in Relapsed/Refractory DLBCL - Mehdi Hamadani, MD                   

11:45am -12:05pm | Updates in Mantle Cell Lymphoma - Timothy Fenske, MD, MS       

12:05-12:20pm | Lymphoma Panel Discussion - All Speakers            

12:20pm | Adjourn

Milwaukee, WI 53203
United States

This event will be held virtually. A link will be sent in the weeks proceeding the symposium. At the conclusion of the event, attendees will be follow a link to log into Ethos to complete an evaluation and claim their CME. 

Guest Speakers

Jane Churpek, MD, MS
Assistant Professor
Division of Hematology, Oncology and Palliative Care
University of Wisconsin School of Medicine and Public Health

Suzanne Lentzsch, MD, PhD
Department of Medicine
Division of Hematology/Oncology
Director, Multiple Myeloma & Amyloidosis Program

Columbia University
Herbert Irving Comprehensive Cancer Center

Froedtert and the Medical College of Wisconsin Speakers

Saurabh Chhabra, MD, MS
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Sumana Devata, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
 
Timothy Fenske, MD
Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
 

Mehdi Hamadani, MD
Professor of Internal Medicine
Division of Hematology & Oncology
Medical College of Wisconsin 

Laura Michaelis, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin

Meera Mohan, MD, MS, FACP
Instructor
Division of Hematology & Oncology
Medical College of Wisconsin

Guru Subramanian Guru Murthy, MD, MS
Assistant Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin

Planning Committee

Sameem Abedin, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin 

Lyndsey Runaas, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Dan Bullock
Education Program Coordinator
Division of Hematology and Oncology
Medical College of Wisconsin

Catherine Sestito, APNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin


All persons in control of content have NO relevant financial relationships to dislose with the exception of:

NameCompanyRole
Guru Subramanian Guru Murthy, MD, MS
Cardinal Health
 
Cancer Expert Now

Advisory Board

Speaking

Jane Churpek, MDUpToDate, Inc.Author
Timothy Fenske, MD

Genentech. Adaptive Biotechnologies, AbbVie, Verastem, Kite MorphoSys

Seattle Genetics, AstraZeneca,Celgene, Adaptive Biotechnologies

Millennium, Kyowa. TG Therapeutics, Portola, Curis

Consultant

Speaking

Research Funding

Mehdi Hamadani, MD

Incyte, Celgene, ADC Therapeutics

Takeda, Otsuka Pharmaceutical, Spectrum Pharmaceuticals, Astellas

Consultant

Research Funding

 

 

 

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.

Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number XXXXXX.  This program has been approved for 3.75 contact hours of continuing education (which includes 0.75 hours of pharmacology).

 

Available Credit

  • 3.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.75 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
  • 3.75 NP Contact Hours

Price

Cost:
$0.00
Please login or register to take this course.

This activity is complementary, however registration is required. To register for this course click the "Take Course" button above.